SEC Form 4 · accession 0001209191-15-011614
CELGENE CORP /DE/ · CELG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Perry A Karsen
Officer — see remarks
Period of report
Feb 6, 2015
Accepted (ET)
Feb 10, 2015 · 6:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816284
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 6, 2015 | A | 30,404 | $0.00 | A | 85,875 | D | |
| Common Stock | Feb 6, 2015 | F | 15,758 | $118.75 | D | 70,117 | D | |
| Common Stock | holding | — | — | — | 2,000 | I | IRA Account | |
| Common Stock | holding | — | — | — | 1,461 | I | 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock relating to the 2012-2014 Long Term Incentive Plan and issued under the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013).
Remarks
Chief Executive Officer, Celgene Cellular Therapeutics